We are live on ! Find out more
BRM

Boston Research & Management Portfolio holdings

AUM $421M
1-Year Est. Return 16.18%
This Fund
S&P 500
This Quarter Est. Return
+3.57%
1 Year Est. Return
+16.18%
3 Year Est. Return
+48.21%
5 Year Est. Return
+65.09%
10 Year Est. Return
+242.1%
AUM
$118M
AUM Growth
+$5.92M
Cap. Flow
+$2.18M
Cap. Flow %
1.84%
Top 10 Hldgs %
23.44%
Holding
89
New
6
Increased
35
Reduced
24
Closed
–

Top Buys

Rank Stock Value
1
EFOR
Everforth Inc
EFOR
+$232K
2
XYL icon
Xylem
XYL
+$232K
3
DD
Du Pont De Nemours E I
DD
+$221K
4
GAS
AGL Resources Inc
GAS
+$209K
5
GPC icon
Genuine Parts
GPC
+$206K

Top Sells

Rank Stock Value
1
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
+$169K
2
WU icon
Western Union
WU
+$89.5K
3
IWM icon
iShares Russell 2000 ETF
IWM
+$86.9K
4
MMM icon
3M
MMM
+$75.9K
5
STT icon
State Street
STT
+$62.3K

Sector Composition

Rank Sector Weight
1 Industrials 14.03%
2 Technology 12.71%
3 Consumer Staples 11.34%
4 Healthcare 10.79%
5 Financials 9.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
STT icon
51
State Street
STT
$48.4B
$971K 0.82%
14,770
-910
-6% -$62.3K
JNJ icon
52
Johnson & Johnson
JNJ
$640B
$922K 0.78%
10,640
– –
ABT icon
53
Abbott
ABT
$188B
$873K 0.74%
26,312
+3,147
+14% +$110K
VEU icon
54
Vanguard FTSE All-World ex-US ETF
VEU
$64.8B
$857K 0.72%
17,635
– –
PG icon
55
Procter & Gamble
PG
$340B
$823K 0.7%
10,899
– –
AOR icon
56
iShares Core 60/40 Balanced Allocation ETF
AOR
$3.61B
$783K 0.66%
21,262
+1,140
+6% +$41.4K
AMLP icon
57
Alerian MLP ETF
AMLP
$12.9B
$777K 0.66%
8,844
+362
+4% +$31.9K
HD icon
58
Home Depot
HD
$337B
$755K 0.64%
9,960
– –
BBH icon
59
VanEck Biotech ETF
BBH
$406M
$750K 0.63%
9,075
-150
-2% -$11.8K
AMJ
60
DELISTED
JP Morgan Alerian MLP Index ETN 5/24/24
AMJ
$742K 0.63%
16,640
– –
IBM icon
61
IBM
IBM
$213B
$673K 0.57%
3,802
+31
+0.8% +$5.63K
DUK icon
62
Duke Energy
DUK
$101B
$563K 0.48%
8,431
+184
+2% +$12.6K
BXP icon
63
Boston Properties
BXP
$11.6B
$522K 0.44%
4,885
– –
PFE icon
64
Pfizer
PFE
$143B
$502K 0.42%
18,426
– –
DIS icon
65
Walt Disney
DIS
$171B
$436K 0.37%
6,770
– –
JPM icon
66
JPMorgan Chase
JPM
$916B
$406K 0.34%
7,866
– –
LLY icon
67
Eli Lilly
LLY
$1.08T
$376K 0.32%
7,485
– –
KMB icon
68
Kimberly-Clark
KMB
$37.6B
$374K 0.32%
4,144
+76
+2% +$7.04K
MRK icon
69
Merck
MRK
$322B
$349K 0.29%
7,695
– –
SYY icon
70
Sysco
SYY
$40.8B
$333K 0.28%
10,465
– –
CTAS icon
71
Cintas
CTAS
$86.6B
$331K 0.28%
25,916
– –
PAYX icon
72
Paychex
PAYX
$43.4B
$320K 0.27%
7,875
– –
SYK icon
73
Stryker
SYK
$135B
$319K 0.27%
4,724
– –
PPG icon
74
PPG Industries
PPG
$24.9B
$309K 0.26%
3,700
– –
YUM icon
75
Yum! Brands
YUM
$41.9B
$308K 0.26%
6,009
– –
1 2
3
4

Similar funds

SCV
Sands Capital Ventures Arlington, Virginia $421M AUM 26.25% 1-Year Est. Return
TFP
Triune Financial Partners Overland Park, Kansas $421M AUM 22.09% 1-Year Est. Return
MG
MilWealth Group Milwaukee, Wisconsin $420M AUM 12.37% 1-Year Est. Return
HWMG
Hurlow Wealth Management Group Bloomington, Indiana $420M AUM 16.85% 1-Year Est. Return
AI
ArchPoint Investors Coral Gables, Florida $420M AUM 42.19% 1-Year Est. Return
IMA
Investment Management Associates Greenwood Village, Colorado $420M AUM 11.81% 1-Year Est. Return
GPA
Guidance Point Advisors Wellesley, Massachusetts $422M AUM 16.47% 1-Year Est. Return
CMHI
CVC Management Holdings II St. Helier, Jersey $420M AUM 0.05% 1-Year Est. Return

Boston Research & Management's Q3 2013 Portfolio in Review

As of Q3 2013, Boston Research & Management held 89 positions worth $118M, up 5.3% from $112M the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Boston Research & Management's Q3 2013 filing shows 6 new, 35 increased and 24 reduced positions. Its largest new stake was Everforth Inc: 7,482 shares worth $246K. The largest sale was COVIDIEN PLC COM SHS NEW (IRELAND), an estimated $169K.

By sector, the portfolio is most concentrated in Industrials at 14% of assets, up from 14% a quarter earlier, followed by Technology and Consumer Staples.

  • Boston Research & Management's largest Q3 2013 buy was Everforth Inc: 7,482 shares worth $246K.
  • Boston Research & Management added most to Xylem in Q3 2013, an estimated $232K increase.
  • Boston Research & Management's biggest Q3 2013 reduction was COVIDIEN PLC COM SHS NEW (IRELAND), cutting an estimated $169K.
  • Boston Research & Management's ten largest holdings make up 23% of its $118M portfolio in Q3 2013.
  • Boston Research & Management opened 6 new positions and closed 0 in Q3 2013.
  • Boston Research & Management's portfolio value rose 5.3% quarter-over-quarter to $118M.

Based on Boston Research & Management's 13F filing for Q3 2013, filed 8 Nov 2013.